ConductScience.org, home

Paper · 305461

Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.

Lee SK and 1 other. J Exp Med, 1978. Cited by 68 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia. Papers, record 305461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/305461

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.
PubMed
Journal
J Exp Med
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
1.95
iCite
Revised in PubMed
2019-05-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee SKS K
2Oliver RTR T

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytotoxicity, ImmunologicMajor topic
Leukemia, Myeloid, AcuteMajor topic
T-LymphocytesMajor topic
HLA Antigens
Humans
Isoantigens
Lymphocyte Activation
Lymphocyte Cooperation

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,139,934IMMUNOLOGY OF EXPERIMENTAL TUMORS.Annu Rev Med1964https://conductscience.org/library/papers/14139934PubMed
263,529Radiation leukemia in C57BL/6 mice. II. Lack of ecotropic virus expression in the majority of lymphomas.J Exp Med1976https://conductscience.org/library/papers/63529PubMed
363,528Radiation leukemia in C57BL/6 mice. I. Lack of serological evidence for the role of endogenous ecotropic viruses in pathogenesis.J Exp Med1976https://conductscience.org/library/papers/63528PubMed
4322,689Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.Br J Cancer1977https://conductscience.org/library/papers/322689PubMed
51,086,826Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera.Immunology1976https://conductscience.org/library/papers/1086826PubMed
61,069,027Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro.J Immunol1976https://conductscience.org/library/papers/1069027PubMed
74,125,685Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.Transplant Proc1973https://conductscience.org/library/papers/4125685PubMed
84,114,812Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer.Br J Cancer1972https://conductscience.org/library/papers/4114812PubMed
94,130,075The specificty and the activation mechanism of cell-mediated lympholysis (CML) in man.Transplant Proc1973https://conductscience.org/library/papers/4130075PubMed
104,140,237Studies on specificity of cell-mediated immunity to human tumors.J Natl Cancer Inst1974https://conductscience.org/library/papers/4140237PubMed

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
8,774,361HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation.Immunology1996https://conductscience.org/library/papers/8774361PubMed
8,513,452Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients.Cancer Immunol Immunother1993https://conductscience.org/library/papers/8513452PubMed
8,512,807Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing.Br J Cancer1993https://conductscience.org/library/papers/8512807PubMed
6,961,951Susceptibility of human leukaemias to cell-mediated cytotoxicity by interferon-treated allogeneic lymphocytes.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6961951PubMed
6,764,836Specific adoptive immunotherapy: experimental basis and future potential.Surv Immunol Res1982https://conductscience.org/library/papers/6764836PubMed
6,626,451Treatment of fresh human leukaemia cells with actinomycin D enhances their lysability by natural killer cells.Br J Cancer1983https://conductscience.org/library/papers/6626451PubMed
6,553,506The role of allogeneic cells in the stimulation of cell-mediated cytotoxicity to leukaemia cells. A family study.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6553506PubMed
6,451,236In vitro stimulation of cell-mediated cytotoxicity by acute leukaemias.Br J Cancer1981https://conductscience.org/library/papers/6451236PubMed
6,450,603In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.Br J Cancer1981https://conductscience.org/library/papers/6450603PubMed
6,446,429Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia.Clin Exp Immunol1980https://conductscience.org/library/papers/6446429PubMed

1 to 10 of 23

See all 23 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/305461

GET https://conductscience.org/api/papers/v1/305461/references?page=2